MyAverix Finance
US · Healthcare
Takeda Pharmaceutical Co Ltd ADR (TAK)
Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical Co Ltd ADR (TAK) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for TAK
Takeda Pharmaceutical Co Ltd ADR (TAK) — FAQ
What is TAK's P/E ratio?
The price-to-earnings (P/E) ratio for Takeda Pharmaceutical Co Ltd ADR (TAK) is 18.00 (data as of 2026-03-23).
Does Takeda Pharmaceutical Co Ltd ADR pay a dividend?
Dividend yield is not available in the current snapshot for Takeda Pharmaceutical Co Ltd ADR (TAK). Check the MyAverix Finance app for the latest dividend data.
What sector is Takeda Pharmaceutical Co Ltd ADR in?
Takeda Pharmaceutical Co Ltd ADR (TAK) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is TAK listed on?
TAK is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.